SPIDOL study protocol for the assessment of intrathecal ziconotide antalgic efficacy for severe refractory neuropathic pain due to spinal cord lesions

Trials 2024 Sep 7;25(1):595. doi: 10.1186/s13063-024-08387-0. Andrei Brinzeu, Julien Berthiller, Nathalie Perreton, Fabien Subtil, Caroline Gervaise, Jacques Luaute, Patrick Mertens; SPIDOL Study Group Collaborators  SPIDOL Study Group: Michel Lanteri-Minet, Brigitte Perrouin Verbe, Bechir Jarraya, Philippe Menei, Jimmy Voirin, Jean-Marie Regis, Kevin Buffenoir, Marc Lefort, Denys Fontaine, Jean Luc Barat Abstract Rationale: Central neuropathic pain resulting from spinal